Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 19, 2022 10:00 AM 15 min read

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022

by Benzinga Insights Benzinga Staff Writer
Follow

Upgrades

For NRG Energy Inc (NYSE:NRG), B of A Securities upgraded the previous rating of Underperform to Neutral. For the third quarter, NRG Energy had an EPS of $0.29, compared to year-ago quarter EPS of $6.60. At the moment, the stock has a 52-week-high of $47.82 and a 52-week-low of $30.64. NRG Energy closed at $31.05 at the end of the last trading period.

According to Northland Capital Markets, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Market Perform to Outperform. In the third quarter, Enphase Energy showed an EPS of $1.25, compared to $0.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $339.92 and a 52-week-low of $113.40. Enphase Energy closed at $303.39 at the end of the last trading period.

According to Raymond James, the prior rating for American Equity Investment Life Holding Co (NYSE:AEL) was changed from Outperform to Strong Buy. For the third quarter, American Equity Inv had an EPS of $1.29, compared to year-ago quarter EPS of $0.85. At the moment, the stock has a 52-week-high of $44.49 and a 52-week-low of $28.05. American Equity Inv closed at $39.13 at the end of the last trading period.

Stifel upgraded the previous rating for Pentair PLC (NYSE:PNR) from Hold to Buy. For the third quarter, Pentair had an EPS of $0.99, compared to year-ago quarter EPS of $0.89. The current stock performance of Pentair shows a 52-week-high of $74.76 and a 52-week-low of $38.55. Moreover, at the end of the last trading period, the closing price was at $43.44.

Atlantic Equities upgraded the previous rating for Warner Music Group Corp (NASDAQ:WMG) from Neutral to Overweight. Warner Music Gr earned $0.32 in the fourth quarter, compared to $0.12 in the year-ago quarter. The stock has a 52-week-high of $44.64 and a 52-week-low of $21.57. At the end of the last trading period, Warner Music Gr closed at $33.64.

According to Jefferies, the prior rating for Moderna Inc (NASDAQ:MRNA) was changed from Hold to Buy. Moderna earned $2.53 in the third quarter, compared to $7.70 in the year-ago quarter. At the moment, the stock has a 52-week-high of $321.31 and a 52-week-low of $115.03. Moderna closed at $193.29 at the end of the last trading period.

JP Morgan upgraded the previous rating for Glaukos Corp (NYSE:GKOS) from Underweight to Neutral. In the third quarter, Glaukos showed an EPS of $0.45, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $64.49 and a 52-week-low of $33.33. At the end of the last trading period, Glaukos closed at $42.48.

Keybanc upgraded the previous rating for PerkinElmer Inc (NYSE:PKI) from Sector Weight to Overweight. PerkinElmer earned $1.51 in the third quarter, compared to $2.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $203.16 and a 52-week-low of $113.46. PerkinElmer closed at $137.66 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Synaptogenix Inc (NASDAQ:SNPX), Maxim Group downgraded the previous rating of Buy to Hold. Synaptogenix earned $0.43 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $10.65 and a 52-week-low of $1.08. At the end of the last trading period, Synaptogenix closed at $1.20.

For AT&T Inc (NYSE:T), MoffettNathanson downgraded the previous rating of Market Perform to Underperform. For the third quarter, AT&T had an EPS of $0.68, compared to year-ago quarter EPS of $0.87. The stock has a 52-week-high of $27.48 and a 52-week-low of $14.46. At the end of the last trading period, AT&T closed at $18.49.

According to Oppenheimer, the prior rating for Tesla Inc (NASDAQ:TSLA) was changed from Outperform to Perform. Tesla earned $1.05 in the third quarter, compared to $0.62 in the year-ago quarter. At the moment, the stock has a 52-week-high of $402.67 and a 52-week-low of $150.04. Tesla closed at $150.23 at the end of the last trading period.

According to HC Wainwright & Co., the prior rating for Bionomics Ltd (NASDAQ:BNOX) was changed from Buy to Neutral.

Stifel downgraded the previous rating for Xylem Inc (NYSE:XYL) from Buy to Hold. For the third quarter, Xylem had an EPS of $0.79, compared to year-ago quarter EPS of $0.63. At the moment, the stock has a 52-week-high of $121.47 and a 52-week-low of $72.08. Xylem closed at $109.91 at the end of the last trading period.

For Vtex (NYSE:VTEX), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Vtex earned $0.06 in the third quarter, compared to $0.12 in the year-ago quarter. The stock has a 52-week-high of $12.88 and a 52-week-low of $2.66. At the end of the last trading period, Vtex closed at $3.52.

JP Morgan downgraded the previous rating for Baxter International Inc (NYSE:BAX) from Overweight to Neutral. In the third quarter, Baxter Intl showed an EPS of $0.82, compared to $1.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $89.70 and a 52-week-low of $49.47. Baxter Intl closed at $49.71 at the end of the last trading period.

According to Deutsche Bank, the prior rating for Invesco Ltd (NYSE:IVZ) was changed from Buy to Hold. In the third quarter, Invesco showed an EPS of $0.34, compared to $0.77 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.33 and a 52-week-low of $13.20. Invesco closed at $18.39 at the end of the last trading period.

According to Keybanc, the prior rating for Catalent Inc (NYSE:CTLT) was changed from Overweight to Sector Weight. In the first quarter, Catalent showed an EPS of $0.34, compared to $0.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $130.97 and a 52-week-low of $40.69. Catalent closed at $44.26 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

BTIG initiated coverage on Glass House Brands Inc (OTC:GLASF) with a Buy rating. The price target for Glass House Brands is set to $6.00. At the moment, the stock has a 52-week-high of $6.54 and a 52-week-low of $1.95. Glass House Brands closed at $2.32 at the end of the last trading period.

William Blair initiated coverage on NewAmsterdam Pharma Co NV (NASDAQ:NAMS) with an Outperform rating. The stock has a 52-week-high of $32.88 and a 52-week-low of $7.52. At the end of the last trading period, NewAmsterdam Pharma closed at $10.71.

With a Buy rating, Jefferies initiated coverage on NewAmsterdam Pharma Co NV (NASDAQ:NAMS). The price target seems to have been set at $24.00 for NewAmsterdam Pharma. At the moment, the stock has a 52-week-high of $32.88 and a 52-week-low of $7.52. NewAmsterdam Pharma closed at $10.71 at the end of the last trading period.

Cowen & Co. initiated coverage on DZS Inc (NASDAQ:DZSI) with an Outperform rating. The price target for DZS is set to $25.00. For the third quarter, DZS had an EPS of $0.05, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $19.95 and a 52-week-low of $10.59. At the end of the last trading period, DZS closed at $11.01.

Roth Capital initiated coverage on Tempo Automation Holdings Inc (NASDAQ:TMPO) with a Buy rating. The price target for Tempo Automation Holdings is set to $5.00. At the moment, the stock has a 52-week-high of $15.15 and a 52-week-low of $1.05. Tempo Automation Holdings closed at $1.06 at the end of the last trading period.

Loop Capital initiated coverage on MasterBrand Inc (NYSE:MBC) with a Hold rating. The price target for MasterBrand is set to $9.00. At the moment, the stock has a 52-week-high of $9.33 and a 52-week-low of $7.46. MasterBrand closed at $9.30 at the end of the last trading period.

With a Market Perform rating, Keefe, Bruyette & Woods initiated coverage on California Bancorp (NASDAQ:CALB). The price target seems to have been set at $29.00 for California Bancorp. In the third quarter, California Bancorp showed an EPS of $0.66, compared to $0.39 from the year-ago quarter.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
ACXP Logo
ACXPAcurx Pharmaceuticals Inc
$1.972.95%
Overview
AEP Logo
AEPAmerican Electric Power Co Inc
$126.881.74%
AMP Logo
AMPAmeriprise Financial Inc
$477.092.10%
AXS Logo
AXSAxis Capital Holdings Ltd
$101.190.08%
BAX Logo
BAXBaxter International Inc
$18.755.67%
EARN Logo
EARNEllington Credit Co
$5.25-0.29%
ENPH Logo
ENPHEnphase Energy Inc
$44.260.26%
FG Logo
FGF&G Annuities & Life Inc
$28.250.16%
GKOS Logo
GKOSGlaukos Corp
$106.741.20%
GLASF Logo
GLASFGlass House Brands Inc
$7.930.51%
IVZ Logo
IVZInvesco Ltd
$26.460.88%
LHX Logo
LHXL3Harris Technologies Inc
$348.192.44%
LPX Logo
LPXLouisiana-Pacific Corp
$94.420.57%
MAIN Logo
MAINMain Street Capital Corp
$59.00-3.10%
MBC Logo
MBCMasterBrand Inc
$11.993.63%
MRNA Logo
MRNAModerna Inc
$42.786.67%
NAMS Logo
NAMSNewAmsterdam Pharma Co NV
$35.261.15%
NLY Logo
NLYAnnaly Capital Management Inc
$23.080.65%
NRG Logo
NRGNRG Energy Inc
$166.663.00%
PNR Logo
PNRPentair PLC
$99.421.31%
RJF Logo
RJFRaymond James Financial Inc
$157.990.37%
SNPX Logo
SNPXTradr 2X Long SNPS Daily ETF
$28.627.80%
T Logo
TAT&T Inc
$28.67-0.95%
TSLA Logo
TSLATesla Inc
$414.11-0.71%
VNRX Logo
VNRXVolitionRX Ltd
$0.2300-2.21%
VRDN Logo
VRDNViridian Therapeutics Inc
$29.161.41%
VRTX Logo
VRTXVertex Pharmaceuticals Inc
$494.086.25%
VTEX Logo
VTEXVtex
$3.100.16%
VTYX Logo
VTYXVentyx Biosciences Inc
$13.940.11%
WM Logo
WMWaste Management Inc
$233.681.15%
WMG Logo
WMGWarner Music Group Corp
$29.212.31%
XYL Logo
XYLXylem Inc
$127.501.44%

According to TD Securities, the prior rating for Maxar Technologies Inc (NYSE:MAXR) was changed from Buy to Tender. For the third quarter, Maxar Technologies had an EPS of $0.05, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $51.93 and a 52-week-low of $17.51. At the end of the last trading period, Maxar Technologies closed at $51.93.

According to B of A Securities, the prior rating for American Electric Power Co Inc (NASDAQ:AEP) was changed from Buy to Neutral. For the third quarter, American Electric Power had an EPS of $1.62, compared to year-ago quarter EPS of $1.43. At the moment, the stock has a 52-week-high of $105.60 and a 52-week-low of $80.30. American Electric Power closed at $94.57 at the end of the last trading period.

For Raymond James Financial Inc (NYSE:RJF), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Raymond James Finl showed an EPS of $2.08, compared to $2.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $126.00 and a 52-week-low of $84.86. Raymond James Finl closed at $106.75 at the end of the last trading period.

According to TD Securities, the prior rating for Louisiana-Pacific Corp (NYSE:LPX) was changed from Buy to Hold. In the third quarter, Louisiana-Pacific showed an EPS of $1.72, compared to $3.87 from the year-ago quarter. The current stock performance of Louisiana-Pacific shows a 52-week-high of $79.77 and a 52-week-low of $48.20. Moreover, at the end of the last trading period, the closing price was at $61.85.

According to RBC Capital, the prior rating for Maxar Technologies Inc (NYSE:MAXR) was changed from Outperform to Sector Perform. Maxar Technologies earned $0.05 in the third quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.93 and a 52-week-low of $17.51. Maxar Technologies closed at $51.93 at the end of the last trading period.

According to Stifel, the prior rating for Waste Management Inc (NYSE:WM) was changed from Buy to Hold. For the third quarter, Waste Management had an EPS of $1.56, compared to year-ago quarter EPS of $1.26. At the moment, the stock has a 52-week-high of $175.98 and a 52-week-low of $138.58. Waste Management closed at $161.79 at the end of the last trading period.

According to Baird, the prior rating for Maxar Technologies Inc (NYSE:MAXR) was changed from Outperform to Neutral. For the third quarter, Maxar Technologies had an EPS of $0.05, compared to year-ago quarter EPS of $0.19. The current stock performance of Maxar Technologies shows a 52-week-high of $51.93 and a 52-week-low of $17.51. Moreover, at the end of the last trading period, the closing price was at $51.93.

For L3Harris Technologies Inc (NYSE:LHX), Baird downgraded the previous rating of Outperform to Neutral. In the third quarter, L3Harris Technologies showed an EPS of $3.26, compared to $3.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $279.71 and a 52-week-low of $200.71. L3Harris Technologies closed at $213.27 at the end of the last trading period.

According to Jefferies, the prior rating for Aerojet Rocketdyne Holdings Inc (NYSE:AJRD) was changed from Buy to Hold. Aerojet Rocketdyne Hldgs earned $0.45 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Aerojet Rocketdyne Hldgs shows a 52-week-high of $56.00 and a 52-week-low of $35.47. Moreover, at the end of the last trading period, the closing price was at $54.89.

According to Jefferies, the prior rating for Vertex Pharmaceuticals Inc (NASDAQ:VRTX) was changed from Buy to Hold. In the third quarter, Vertex Pharmaceuticals showed an EPS of $4.01, compared to $3.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $324.75 and a 52-week-low of $210.35. Vertex Pharmaceuticals closed at $304.80 at the end of the last trading period.

Keefe, Bruyette & Woods downgraded the previous rating for Axis Capital Holdings Ltd (NYSE:AXS) from Outperform to Market Perform. Axis Capital Holdings earned $0.03 in the third quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $61.39 and a 52-week-low of $48.32. At the end of the last trading period, Axis Capital Holdings closed at $54.67.

According to Keefe, Bruyette & Woods, the prior rating for Ameriprise Financial Inc (NYSE:AMP) was changed from Outperform to Market Perform. In the third quarter, Ameriprise Financial showed an EPS of $6.43, compared to $5.91 from the year-ago quarter. The stock has a 52-week-high of $339.41 and a 52-week-low of $219.99. At the end of the last trading period, Ameriprise Financial closed at $312.18.

For Ellington Residential Mortgage REIT (NYSE:EARN), JonesTrading initiated coverage, by setting the current rating at Hold. Ellington Residential earned $0.23 in the third quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.07 and a 52-week-low of $5.70. Ellington Residential closed at $7.03 at the end of the last trading period.

With a Buy rating, Lake Street initiated coverage on Apollo Medical Holdings Inc (NASDAQ:AMEH). The price target seems to have been set at $40.00 for Apollo Medical Hlgs. In the third quarter, Apollo Medical Hlgs showed an EPS of $0.56, compared to $0.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $75.23 and a 52-week-low of $26.89. Apollo Medical Hlgs closed at $31.14 at the end of the last trading period.

With a Buy rating, EF Hutton initiated coverage on Acasti Pharma Inc (NASDAQ:ACST). The price target seems to have been set at $2.50 for Acasti Pharma. Acasti Pharma earned $0.11 in the second quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Acasti Pharma shows a 52-week-high of $1.79 and a 52-week-low of $0.34. Moreover, at the end of the last trading period, the closing price was at $0.38.

EF Hutton initiated coverage on Pineapple Energy Inc (NASDAQ:PEGY) with a Buy rating. The price target for Pineapple Energy is set to $5.50. For the third quarter, Pineapple Energy had an EPS of $0.34, compared to year-ago quarter EPS of $0.18. The current stock performance of Pineapple Energy shows a 52-week-high of $7.60 and a 52-week-low of $0.76. Moreover, at the end of the last trading period, the closing price was at $1.66.

With a Buy rating, EF Hutton initiated coverage on Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN). The price target seems to have been set at $6.70 for Sonnet BioTherapeutics. For the fourth quarter, Sonnet BioTherapeutics had an EPS of $1.66, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $9.37 and a 52-week-low of $0.96. At the end of the last trading period, Sonnet BioTherapeutics closed at $0.96.

With a Buy rating, EF Hutton initiated coverage on VolitionRX Ltd (AMEX:VNRX). The price target seems to have been set at $6.00 for VolitionRX. For the third quarter, VolitionRX had an EPS of $0.14, compared to year-ago quarter EPS of $0.13. The current stock performance of VolitionRX shows a 52-week-high of $3.57 and a 52-week-low of $1.31. Moreover, at the end of the last trading period, the closing price was at $2.13.

Needham initiated coverage on Viridian Therapeutics Inc (NASDAQ:VRDN) with a Buy rating. The price target for Viridian Therapeutics is set to $45.00. In the third quarter, Viridian Therapeutics showed an EPS of $0.86, compared to $1.25 from the year-ago quarter. The stock has a 52-week-high of $28.86 and a 52-week-low of $9.47. At the end of the last trading period, Viridian Therapeutics closed at $27.88.

UBS initiated coverage on Main Street Capital Corp (NYSE:MAIN) with a Neutral rating. The price target for Main Street Capital is set to $40.00. Main Street Capital earned $0.83 in the third quarter, compared to $0.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $45.67 and a 52-week-low of $31.66. Main Street Capital closed at $37.00 at the end of the last trading period.

With a Equal-Weight rating, Barclays initiated coverage on F&G Annuities & Life Inc (NYSE:FG). The price target seems to have been set at $22.00 for F&G Annuities & Life. F&G Annuities & Life earned $0.30 in the first quarter, compared to $0.37 in the year-ago quarter. The stock has a 52-week-high of $22.00 and a 52-week-low of $17.34. At the end of the last trading period, F&G Annuities & Life closed at $19.56.

HC Wainwright & Co. initiated coverage on Acurx Pharmaceuticals Inc (NASDAQ:ACXP) with a Buy rating. The price target for Acurx Pharmaceuticals is set to $14.00. For the third quarter, Acurx Pharmaceuticals had an EPS of $0.32, compared to year-ago quarter EPS of $0.46. The stock has a 52-week-high of $4.89 and a 52-week-low of $2.33. At the end of the last trading period, Acurx Pharmaceuticals closed at $3.83.

With a Buy rating, JonesTrading initiated coverage on Annaly Capital Management Inc (NYSE:NLY). The price target seems to have been set at $22.50 for Annaly Capital Management. Annaly Capital Management earned $1.06 in the third quarter, compared to $1.12 in the year-ago quarter. The stock has a 52-week-high of $33.32 and a 52-week-low of $15.11. At the end of the last trading period, Annaly Capital Management closed at $21.39.

Goldman Sachs initiated coverage on Ventyx Biosciences Inc (NASDAQ:VTYX) with a Buy rating. The price target for Ventyx Biosciences is set to $50.00. In the third quarter, Ventyx Biosciences showed an EPS of $0.59, compared to $3.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $41.29 and a 52-week-low of $9.50. Ventyx Biosciences closed at $32.64 at the end of the last trading period.

ACXP Logo
ACXPAcurx Pharmaceuticals Inc
$1.972.95%
Overview
AEP Logo
AEPAmerican Electric Power Co Inc
$126.881.74%
AMP Logo
AMPAmeriprise Financial Inc
$477.092.10%
AXS Logo
AXSAxis Capital Holdings Ltd
$101.190.08%
BAX Logo
BAXBaxter International Inc
$18.755.67%
EARN Logo
EARNEllington Credit Co
$5.25-0.29%
ENPH Logo
ENPHEnphase Energy Inc
$44.260.26%
FG Logo
FGF&G Annuities & Life Inc
$28.250.16%
GKOS Logo
GKOSGlaukos Corp
$106.741.20%
GLASF Logo
GLASFGlass House Brands Inc
$7.930.51%
IVZ Logo
IVZInvesco Ltd
$26.460.88%
LHX Logo
LHXL3Harris Technologies Inc
$348.192.44%
LPX Logo
LPXLouisiana-Pacific Corp
$94.420.57%
MAIN Logo
MAINMain Street Capital Corp
$59.00-3.10%
MBC Logo
MBCMasterBrand Inc
$11.993.63%
MRNA Logo
MRNAModerna Inc
$42.786.67%
NAMS Logo
NAMSNewAmsterdam Pharma Co NV
$35.261.15%
NLY Logo
NLYAnnaly Capital Management Inc
$23.080.65%
NRG Logo
NRGNRG Energy Inc
$166.663.00%
PNR Logo
PNRPentair PLC
$99.421.31%
RJF Logo
RJFRaymond James Financial Inc
$157.990.37%
SNPX Logo
SNPXTradr 2X Long SNPS Daily ETF
$28.627.80%
T Logo
TAT&T Inc
$28.67-0.95%
TSLA Logo
TSLATesla Inc
$414.11-0.71%
VNRX Logo
VNRXVolitionRX Ltd
$0.2300-2.21%
VRDN Logo
VRDNViridian Therapeutics Inc
$29.161.41%
VRTX Logo
VRTXVertex Pharmaceuticals Inc
$494.086.25%
VTEX Logo
VTEXVtex
$3.100.16%
VTYX Logo
VTYXVentyx Biosciences Inc
$13.940.11%
WM Logo
WMWaste Management Inc
$233.681.15%
WMG Logo
WMGWarner Music Group Corp
$29.212.31%
XYL Logo
XYLXylem Inc
$127.501.44%
Comments
Loading...